By Debdeep Gupta | 09 Dec, 2024
Brokerage Radar: Jefferies recommends 'Buy' on Sun Pharma, CLSA rates NHPC 'Outperform'
Check out the latest brokerage calls and analyst comments on the stocks in action today. Our coverage includes Sun Pharma, RIL, Tata Power, and more.Jefferies On Sun PharmaBuy Call, Target `2,150/ShAnalysis Of Latest Cancer Treatment Specialty Assets Suggest Combined Peak Sales Of $100 mOther Indications Are Still In the Trial Stage & Thus Present An Option ValuePeak Sales Are ModestCo Should Leve...
Live Comments